{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:47:51Z","timestamp":1790192871148,"version":"4.1.0"},"reference-count":26,"publisher":"Consilium Medicum","issue":"8","license":[{"start":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T00:00:00Z","timestamp":1726272000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Terapevticheskii arkhiv"],"abstract":"<jats:p>Aim. To evaluate the clinical effectiveness, safety and compare the incidence of hospitalization during treatment with antiviral drugs with a direct mechanism of action (riamilovir and umifenovir) in people with acute respiratory viral infections (ARVI) in an outpatient setting.\r\nMaterials and methods. The study included 150 outpatients with ARVI aged 18\u201327 years: 50 patients received riamilovir 250 mg 3 times a day for 5 days, the second group included 50 patients who received umifenovir 200 mg 4 times a day for 5 days, 50 individuals received only pathogenetic treatment.\r\nResults. The use of direct-acting antiviral drugs was characterized by the least severity of pain and aches in the body, general weakness, and in the group of patients receiving riamilovir, the lowest severity of rhinitis, cough, and the lowest morning body temperature were recorded compared to other groups. In riamilovir group reduction in the duration of the disease was observed. The lowest frequency of ARVI pathogens detection was observed on the 6th day in riamilovir group. Outpatient treatment with riamilovir was accompanied by a minimal number of cases of the disease requiring hospitalization.\r\nConclusion. The use of direct antiviral drugs contributes to the rapid relief of ARVI symptoms in patients receiving medical care on an outpatient basis. The antiviral drug riamilovir showed the most pronounced effectiveness (clinical and laboratory).<\/jats:p>","DOI":"10.26442\/00403660.2024.08.202911","type":"journal-article","created":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T00:03:04Z","timestamp":1726272184000},"page":"797-803","source":"Crossref","is-referenced-by-count":5,"title":["Comparative assessment of the clinical effectiveness of direct-acting antiviral drugs in outpatient patients with acute respiratory viral infections"],"prefix":"10.26442","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4398-7525","authenticated-orcid":false,"given":"Konstantin V.","family":"Kozlov","sequence":"additional","affiliation":[{"name":"Kirov Military Medical Academy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6286-9946","authenticated-orcid":false,"given":"Oleg V.","family":"Maltsev","sequence":"additional","affiliation":[{"name":"Kirov Military Medical Academy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9294-7346","authenticated-orcid":false,"given":"Kristina V.","family":"Kasyanenko","sequence":"additional","affiliation":[{"name":"Kirov Military Medical Academy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0468-0165","authenticated-orcid":false,"given":"Vitalii S.","family":"Sukachev","sequence":"additional","affiliation":[{"name":"Kirov Military Medical Academy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9163-7012","authenticated-orcid":false,"given":"Yuri I.","family":"Lyashenko","sequence":"additional","affiliation":[{"name":"Kirov Military Medical Academy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9738-6709","authenticated-orcid":false,"given":"Anastasia A.","family":"Kosuhina","sequence":"additional","affiliation":[{"name":"Kirov Military Medical Academy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18344","published-online":{"date-parts":[[2024,9,14]]},"reference":[{"key":"ref1","unstructured":"\u041a\u0430\u043b\u044e\u0436\u0438\u043d \u041e.\u0412. \u041e\u0441\u0442\u0440\u044b\u0435 \u0440\u0435\u0441\u043f\u0438\u0440\u0430\u0442\u043e\u0440\u043d\u044b\u0435 \u0432\u0438\u0440\u0443\u0441\u043d\u044b\u0435 \u0438\u043d\u0444\u0435\u043a\u0446\u0438\u0438: \u0441\u043e\u0432\u0440\u0435\u043c\u0435\u043d\u043d\u044b\u0435 \u0432\u044b\u0437\u043e\u0432\u044b, \u043f\u0440\u043e\u0442\u0438\u0432\u043e\u0432\u0438\u0440\u0443\u0441\u043d\u044b\u0439 \u043e\u0442\u0432\u0435\u0442, \u0438\u043c\u043c\u0443\u043d\u043e\u043f\u0440\u043e\u0444\u0438\u043b\u0430\u043a\u0442\u0438\u043a\u0430 \u0438 \u0438\u043c\u043c\u0443\u043d\u043e\u0442\u0435\u0440\u0430\u043f\u0438\u044f. \u041c.: \u041c\u0418\u0410, 2014 [Kalyuzhin OV. Ostrye respiratornye virusnye infektsii: sovremennye vyzovy, protivovirusnyi otvet, immunoprofilaktika i immunoterapiia. Moscow: MIA, 2014 (in Russian)]."},{"key":"ref2","unstructured":"\u0420\u043e\u043c\u0430\u043d\u0446\u043e\u0432 \u041c.\u0413., \u041a\u0438\u0441\u0435\u043b\u0435\u0432 \u041e.\u0418., \u0421\u043e\u043b\u043e\u0433\u0443\u0431 \u0422.\u0412. \u042d\u0442\u0438\u043e\u043f\u0430\u0442\u043e\u0433\u0435\u043d\u0435\u0442\u0438\u0447\u0435\u0441\u043a\u0430\u044f \u0444\u0430\u0440\u043c\u0430\u043a\u043e\u0442\u0435\u0440\u0430\u043f\u0438\u044f \u041e\u0420\u0412\u0418 \u0438 \u0433\u0440\u0438\u043f\u043f\u0430. \u041b\u0435\u0447\u0430\u0449\u0438\u0439 \u0432\u0440\u0430\u0447. 2011:2 [Romantsov MG, Kiselev OI, Sologub TV. Etiopatogeneticheskaia farmakoterapiia ORVI i grippa. Lechashchii vrach. 2011:2 (in Russian)]."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(00)00651-3"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.37489\/0235-2990-2021-66-5-6-48-57"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.21518\/2079-701X-2016-4-68-73"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.22625\/2072-6732-2014-6-3-62-70"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.22625\/2072-6732-2019-11-3-20-26"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009332"},{"key":"ref9","unstructured":"\u041f\u0435\u0442\u0440\u043e\u0432 \u0412.\u0418., \u041b\u0435\u043d\u0435\u0432\u0430 \u0418.\u0410., \u041d\u0435\u0434\u043e\u0433\u043e\u0434\u0430 \u0421.\u0412. \u041f\u0440\u0438\u043c\u0435\u043d\u0435\u043d\u0438\u0435 \u043e\u0442\u0435\u0447\u0435\u0441\u0442\u0432\u0435\u043d\u043d\u043e\u0433\u043e \u043f\u0440\u043e\u0442\u0438\u0432\u043e\u0432\u0438\u0440\u0443\u0441\u043d\u043e\u0433\u043e \u043f\u0440\u0435\u043f\u0430\u0440\u0430\u0442\u0430 \u0441 \u043f\u043e\u0437\u0438\u0446\u0438\u0439 \u0434\u043e\u043a\u0430\u0437\u0430\u0442\u0435\u043b\u044c\u043d\u043e\u0439 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u044b. \u041b\u0435\u0447\u0430\u0449\u0438\u0439 \u0432\u0440\u0430\u0447. 2011;1:71-9 [Petrov VI, Leneva IA, Nedogoda SV. Primenenie otechestvennogo protivovirusnogo preparata s pozitsii dokazatel\u2019noi meditsiny. Lechashchii vrach. 2011;1:71-9 (in Russian)]."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.26442\/00403660.2019.03.000127"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.20953\/1729-9225-2017-3-25-32"},{"key":"ref12","unstructured":"\u0411\u0430\u0431\u0430\u043a \u0421.\u041b., \u0413\u043e\u0440\u0435\u043b\u043e\u0432 \u0410.\u0412., \u0417\u0430\u0439\u0446\u0435\u0432 \u0410.\u0410., \u0438 \u0434\u0440. \u0413\u0440\u0438\u043f\u043f \u0443 \u0432\u0437\u0440\u043e\u0441\u043b\u044b\u0445 (\u043a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u0440\u0435\u043a\u043e\u043c\u0435\u043d\u0434\u0430\u0446\u0438\u0438). \u041c.: \u041c\u0417 \u0420\u0424, 2022 [Babak SL, Gorelov AV, Zaitesev AA, et al. Gripp u vzroslykh (klinicheskie rekomendatsii). Moscow: MZ RF, 2022 (in Russian)]."},{"key":"ref13","unstructured":"\u041e\u0441\u0442\u0440\u044b\u0435 \u0440\u0435\u0441\u043f\u0438\u0440\u0430\u0442\u043e\u0440\u043d\u044b\u0435 \u0432\u0438\u0440\u0443\u0441\u043d\u044b\u0435 \u0438\u043d\u0444\u0435\u043a\u0446\u0438\u0438 (\u041e\u0420\u0412\u0418) \u0443 \u0432\u0437\u0440\u043e\u0441\u043b\u044b\u0445. \u041a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u0440\u0435\u043a\u043e\u043c\u0435\u043d\u0434\u0430\u0446\u0438\u0438 \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u0424. \u0420\u0435\u0436\u0438\u043c \u0434\u043e\u0441\u0442\u0443\u043f\u0430: https:\/\/cr.minzdrav.gov.ru\/recomend\/724_1. \u0421\u0441\u044b\u043b\u043a\u0430 \u0430\u043a\u0442\u0438\u0432\u043d\u0430 \u043d\u0430 17.06.2024 [Ostrye respiratornye virusnye infektsii (ORVI) u vzroslykh. Klinicheskie rekomendatsii Minzdrava RF. Available at: https:\/\/cr.minzdrav.gov.ru\/recomend\/724_1. Accessed: 17.06.2024 (in Russin)]."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.26442\/00403660.2020.12.200427"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.20953\/1729-9225-2019-4-13-17"},{"key":"ref16","unstructured":"\u041a\u0438\u0441\u0435\u043b\u0435\u0432 \u041e.\u0418., \u0414\u0435\u0435\u0432\u0430 \u042d.\u0413., \u041c\u0435\u043b\u044c\u043d\u0438\u043a\u043e\u0432\u0430 \u0422.\u0418., \u0438 \u0434\u0440. \u041d\u043e\u0432\u044b\u0439 \u043f\u0440\u043e\u0442\u0438\u0432\u043e\u0432\u0438\u0440\u0443\u0441\u043d\u044b\u0439 \u043f\u0440\u0435\u043f\u0430\u0440\u0430\u0442 \u0422\u0440\u0438\u0430\u0437\u0430\u0432\u0438\u0440\u0438\u043d. \u0420\u0435\u0437\u0443\u043b\u044c\u0442\u0430\u0442\u044b II \u0444\u0430\u0437\u044b \u043a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u043e\u0433\u043e \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u044f. \u0412\u043e\u043f\u0440\u043e\u0441\u044b \u0432\u0438\u0440\u0443\u0441\u043e\u043b\u043e\u0433\u0438\u0438. 2012;57(6):9-12 [Kiselev OI, Deyeva EG, Melnicova TI, et. al. A New antiviral Drug Triazavirin: Results of Phase II Clinical Trial. Voprosy virusologii. 2012;57(6):9-12 (in Russian)]."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.17816\/KMJ2018-215"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.26442\/00403660.2023.11.20247"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.37489\/0235-2990-2023-68-9-10-63-71"},{"key":"ref20","unstructured":"\u041c\u0443\u0448\u043a\u0430\u0440\u043e\u0432 \u0414.\u0420., \u041b\u0435\u043d\u043a\u043e\u0432 \u0414.\u0415., \u0411\u0430\u0445\u0442\u0438\u043d \u0412.\u041c., \u0438 \u0434\u0440. \u041c\u043e\u043b\u0435\u043a\u0443\u043b\u044f\u0440\u043d\u044b\u0439 \u043c\u0435\u0445\u0430\u043d\u0438\u0437\u043c \u0434\u0435\u0439\u0441\u0442\u0432\u0438\u044f \u0443\u043c\u0438\u0444\u0435\u043d\u043e\u0432\u0438\u0440\u0430. \u0410\u043a\u0442\u0443\u0430\u043b\u044c\u043d\u044b\u0435 \u0432\u043e\u043f\u0440\u043e\u0441\u044b \u0441\u043e\u0432\u0440\u0435\u043c\u0435\u043d\u043d\u043e\u0439 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u043e\u0439 \u043d\u0430\u0443\u043a\u0438 \u0438 \u0437\u0434\u0440\u0430\u0432\u043e\u043e\u0445\u0440\u0430\u043d\u0435\u043d\u0438\u044f: \u043c\u0430\u0442\u0435\u0440\u0438\u0430\u043b\u044b VI \u041c\u0435\u0436\u0434\u0443\u043d\u0430\u0440\u043e\u0434\u043d\u043e\u0439 \u043d\u0430\u0443\u0447\u043d\u043e-\u043f\u0440\u0430\u043a\u0442\u0438\u0447\u0435\u0441\u043a\u043e\u0439 \u043a\u043e\u043d\u0444\u0435\u0440\u0435\u043d\u0446\u0438\u0438 \u043c\u043e\u043b\u043e\u0434\u044b\u0445 \u0443\u0447\u0435\u043d\u044b\u0445 \u0438 \u0441\u0442\u0443\u0434\u0435\u043d\u0442\u043e\u0432, \u043f\u043e\u0441\u0432\u044f\u0449\u0435\u043d\u043d\u043e\u0439 \u0433\u043e\u0434\u0443 \u043d\u0430\u0443\u043a\u0438 \u0438 \u0442\u0435\u0445\u043d\u043e\u043b\u043e\u0433\u0438\u0439. 2021;2:1072-7 [Mushkarov DR, Lenkov DE, Bakhtin VM, et al. Umifenovir molecular mechanism of action. Aktual\u2019nye voprosy sovremennoi meditsinskoi nauki i zdravookhraneniia: materialy VI Mezhdunarodnoi nauchno-prakticheskoi konferentsii molodykh uchenykh i studentov, posviashchennoi godu nauki i tekhnologii. 2021;2:1072-7 (in Russian)]."},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"\u041a\u0438\u0441\u0435\u043b\u0435\u0432 \u041e.\u0418., \u041c\u0430\u043b\u0435\u0435\u0432 \u0412.\u0412., \u0414\u0435\u0435\u0432\u0430 \u042d.\u0413., \u0438 \u0434\u0440. \u041a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0430\u044f \u044d\u0444\u0444\u0435\u043a\u0442\u0438\u0432\u043d\u043e\u0441\u0442\u044c \u043f\u0440\u0435\u043f\u0430\u0440\u0430\u0442\u0430 \u0410\u0440\u0431\u0438\u0434\u043e\u043b (\u0443\u043c\u0438\u0444\u0435\u043d\u043e\u0432\u0438\u0440) \u0432 \u0442\u0435\u0440\u0430\u043f\u0438\u0438 \u0433\u0440\u0438\u043f\u043f\u0430 \u0443 \u0432\u0437\u0440\u043e\u0441\u043b\u044b\u0445: \u043f\u0440\u043e\u043c\u0435\u0436\u0443\u0442\u043e\u0447\u043d\u044b\u0435 \u0440\u0435\u0437\u0443\u043b\u044c\u0442\u0430\u0442\u044b \u043c\u043d\u043e\u0433\u043e\u0446\u0435\u043d\u0442\u0440\u043e\u0432\u043e\u0433\u043e \u0434\u0432\u043e\u0439\u043d\u043e\u0433\u043e \u0441\u043b\u0435\u043f\u043e\u0433\u043e \u0440\u0430\u043d\u0434\u043e\u043c\u0438\u0437\u0438\u0440\u043e\u0432\u0430\u043d\u043d\u043e\u0433\u043e \u043f\u043b\u0430\u0446\u0435\u0431\u043e-\u043a\u043e\u043d\u0442\u0440\u043e\u043b\u0438\u0440\u0443\u0435\u043c\u043e\u0433\u043e \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u044f \u0410\u0420\u0411\u0418\u0422\u0420. \u0422\u0435\u0440\u0430\u043f\u0435\u0432\u0442\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0430\u0440\u0445\u0438\u0432. 2015;87(1):88-96 [Kiselev OI, Maleev VV, Deeva EG, et al. Clinical efficacy of \u0410rbidol (umifenovir) in the therapy of influenza in adults: Preliminary results of the multicenter double-blind randomized placebo-controlled study ARBITR. Terapevticheskii Arkhiv (Ter. Arkh.). 2015;87(1):88-96 (in Russian)].","DOI":"10.17116\/terarkh201587188-96"},{"key":"ref22","unstructured":"\u041b\u0435\u043d\u0451\u0432\u0430 \u0418.A., \u0424\u0430\u043b\u044b\u043d\u0441\u043a\u043e\u0432\u0430 \u0418.H., \u041b\u0435\u043e\u043d\u043e\u0432\u0430 \u0415.\u0418., \u0438 \u0434\u0440. \u042d\u0444\u0444\u0435\u043a\u0442\u0438\u0432\u043d\u043e\u0441\u0442\u044c \u0443\u043c\u0438\u0444\u0435\u043d\u043e\u0432\u0438\u0440\u0430 (\u0410\u0440\u0431\u0438\u0434\u043e\u043b\u0430) \u043d\u0430 \u043c\u043e\u0434\u0435\u043b\u0438 \u044d\u043a\u0441\u043f\u0435\u0440\u0438\u043c\u0435\u043d\u0442\u0430\u043b\u044c\u043d\u043e\u0439 \u0441\u043e\u0447\u0435\u0442\u0430\u043d\u043d\u043e\u0439 \u0432\u0438\u0440\u0443\u0441\u043d\u043e-\u0431\u0430\u043a\u0442\u0435\u0440\u0438\u0430\u043b\u044c\u043d\u043e\u0439 \u043f\u043d\u0435\u0432\u043c\u043e\u043d\u0438\u0438 \u043c\u044b\u0448\u0435\u0439. \u0410\u043d\u0442\u0438\u0431\u0438\u043e\u0442\u0438\u043a\u0438 \u0438 \u0445\u0438\u043c\u0438\u043e\u0442\u0435\u0440\u0430\u043f\u0438\u044f. 2014;59(9-10):17-24 [Leneva IA, Falynskova IN, Leonova EI, et al. Umifenovir (Arbidol) Efficacy in Experimental Mixed Viral and Bacterial Pneumonia of Mice. Antibiot Khimioter = Antibiotics and Chemotherapy. 2014;59(9-10):17-24 (in Russian)]."},{"key":"ref23","unstructured":"\u041b\u043e\u0433\u0438\u043d\u043e\u0432\u0430 C.\u042f., \u0411\u043e\u0440\u0438\u0441\u0435\u0432\u0438\u0447 \u0421.\u0412., \u0420\u0443\u0441\u0438\u043d\u043e\u0432 \u0412.\u041b., \u0438 \u0434\u0440. \u0418\u0437\u0443\u0447\u0435\u043d\u0438\u0435 \u043f\u0440\u043e\u0442\u0438\u0432\u043e\u0432\u0438\u0440\u0443\u0441\u043d\u043e\u0439 \u0430\u043a\u0442\u0438\u0432\u043d\u043e\u0441\u0442\u0438 \u0422\u0440\u0438\u0430\u0437\u0430\u0432\u0438\u0440\u0438\u043d\u0430 \u0432 \u043e\u0442\u043d\u043e\u0448\u0435\u043d\u0438\u0438 \u0432\u043e\u0437\u0431\u0443\u0434\u0438\u0442\u0435\u043b\u044f \u0433\u0440\u0438\u043f\u043f\u0430 \u0410 (H5N1) \u0432 \u043a\u0443\u043b\u044c\u0442\u0443\u0440\u0435 \u043a\u043b\u0435\u0442\u043e\u043a. \u0410\u043d\u0442\u0438\u0431\u0438\u043e\u0442\u0438\u043a\u0438 \u0438 \u0445\u0438\u043c\u0438\u043e\u0442\u0435\u0440\u0430\u043f\u0438\u044f. 2007;52(11-12):18-20 [Loginova SYa, Borisevich SV, Rusinov VL, et al. Therapeutic Efficacy of Triazavirin, a Novel Russian Chemotherapeutic, Against Influenza Virus A (H5N1). Antibiotiki i himioterapiya. 2007;52(11-12):18-20 (in Russian)]."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2004.05.024"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2022.02.013"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R110.117531"}],"container-title":["Terapevticheskii arkhiv"],"original-title":[],"link":[{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/634594\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/634594\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T15:00:40Z","timestamp":1733238040000},"score":1,"resource":{"primary":{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/view\/634594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,14]]},"references-count":26,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,9,14]]}},"URL":"https:\/\/doi.org\/10.26442\/00403660.2024.08.202911","relation":{},"ISSN":["2309-5342","0040-3660"],"issn-type":[{"value":"2309-5342","type":"electronic"},{"value":"0040-3660","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,14]]}}}